| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aileron Therapeutics, Inc. | President and CEO | Common Stock | 7.12K | $16K | $2.25 | Dec 5, 2024 | Direct |
| Aileron Therapeutics, Inc. | President and CEO | Common Stock | 161 | $362 | $2.25 | Dec 5, 2024 | By son |
| Aileron Therapeutics, Inc. | President and CEO | Stock Option (right to buy) | 518K | Dec 2, 2024 | Direct | ||
| AILERON THERAPEUTICS INC | President and CEO | Series X Non-Voting Convertible Preferred | 0 | Mar 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALRN | Aileron Therapeutics, Inc. | Dec 5, 2024 | 2 | $898 | 4 | Dec 9, 2024 | President and CEO |
| ALRN | Aileron Therapeutics, Inc. | Dec 2, 2024 | 1 | $0 | 4 | Dec 4, 2024 | President and CEO |
| ALRN | AILERON THERAPEUTICS INC | Mar 5, 2024 | 2 | $0 | 4 | Mar 6, 2024 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Dec 15, 2023 | 1 | $758 | 4 | Dec 18, 2023 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Nov 20, 2023 | 1 | $9.99K | 4 | Nov 21, 2023 | President and COO |
| ALRN | AILERON THERAPEUTICS INC | Oct 31, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Exhibit 24.1 Power of Attorney President and Chief Operating Officer |